NCT03793257 The EXCEL Registry of Patients Requiring ECMO
| NCT ID | NCT03793257 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Australian and New Zealand Intensive Care Research Centre |
| Condition | Critically Ill |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2019-02-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2019-02-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ECMO is associated with significant costs, risks and requires specialist training and expertise. EXCEL is a novel, high-quality, detailed prospective registry of patients requiring ECMO in Australia and New Zealand. The registry provides information on patient selection, complications, costs and patient reported outcome measures. EXCEL uses the Theoretical Domains Framework to identify evidence-practice gaps and explore barriers and enablers to tailor implementation of evidence
Eligibility Criteria
Inclusion Criteria: * Patients admitted to adult hospitals and receive ECMO in Australia and New Zealand Nil Exclusion Criteria
Contact & Investigator
Carol L Hodgson, PhD
STUDY CHAIR
Australian and New Zealand Intensive Care Research Centre
Frequently Asked Questions
Who can join the NCT03793257 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Critically Ill. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03793257 currently recruiting?
Yes, NCT03793257 is actively recruiting participants. Contact the research team at carol.hodgson@monash.edu for enrollment information.
Where is the NCT03793257 trial being conducted?
This trial is being conducted at Canberra, Australia, Camperdown, Australia, Darlinghurst, Australia, Liverpool, Australia and 11 additional locations.
Who is sponsoring the NCT03793257 clinical trial?
NCT03793257 is sponsored by Australian and New Zealand Intensive Care Research Centre. The principal investigator is Carol L Hodgson, PhD at Australian and New Zealand Intensive Care Research Centre. The trial plans to enroll 3,000 participants.